Drugs / CD34+ cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00028600 | Nov 2001 → Jun 2006 | plasma cell myeloma | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00028600 ↗ |
| Route | Intravenous | “2-8,000,000/kg IV infusion allogeneic transplant” NCT00028600 ↗ |